iSOFT Installs e-Prescribing at University Hospitals of Leicester

iSOFTiSOFT, a CSC company, has completed an initial implementation of its e-prescribing and medicines administration solution (ePMA) at the University Hospitals of Leicester NHS Trust, under moves to transform patient safety, clinical outcomes and operational performance.

The project was completed in five months, with the first phase focusing on the bone and marrow transplant unit, oncology and haematology wards, ahead of a roll-out across all wards and departments at the trust's three main hospitals.

The project follows an agreement in June that included iSOFT's ePMA and i.Pharmacy products. This gives Leicester a complete prescribing and medicines management solution to improve dispensing, stock control and further promote medicines good practice across the trust.

"With new and complex medicines being introduced almost on a daily basis, the risk of adverse interactions and clinical errors has increased exponentially," said Beverly Collett, the trust's associate medical director. "Given the sheer volume and complexity of drug information, it is impossible for prescribers to recall all of the potential interactions and their clinical significance. iSOFT's ePMA will support our clinical teams by improving communication and clarity of information, while reducing process complexities that can introduce clinical risk."

The trust is a long standing customer and uses a host of iSOFT patient, clinical and departmental solutions. "This is a clear sign that University Hospitals of Leicester continues to derive genuine value from its partnership with iSOFT," said Adrian Stevens, managing director of iSOFT's UK and Ireland business. "These latest innovations will allow it to build on systems that are familiar and trusted to further improve efficiency and deliver tangible benefits to patients."

iSOFT ePMA provides new opportunities to improve the communication of medicines related information between medical, nursing and clinical pharmacy teams. Advanced drug formulary management, underpinned by clinical and workflow based decision support, provides a highly effective environment to help improve a hospital's performance in relation to medicines. In-built reporting and data analysis tools provide executive and management visibility of performance to help proactively address areas of concern or promote good practice.

Proven at large acute and specialist hospitals in Australia and New Zealand, iSOFT ePMA is shown to halve adverse medication errors that can prolong a patient's stay by up to four days, and so block hospital beds and increase costs.

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

NHS, Councils, and Housing could Share N…

A new technology partnership formally announced, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

AXREM and BHTA Name Highland as 'Fu…

Hosted by trade associations AXREM and the British Healthcare Trades Association (BHTA), 'The Future of MedTech - Innovating for Tomorrow', will allow delegates to engage with speakers from the government...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Call for Papers: AI Applications in Biom…

JMIR Biomedical Engineering is inviting submissions for a new section titled "AI Applications in Biomedical Engineering." This themed section explores the integration of biomedical engineering and artificial intelligence (AI), focusing...